scholarly journals Zero-iodinated contrast retrograde percutaneous coronary interventions of chronic total occlusions using gadolinium and imaging guidance: a case report of a patient with severe anaphylaxis to iodinated contrast

2020 ◽  
Vol 4 (3) ◽  
pp. 1-7 ◽  
Author(s):  
Ankur Gupta ◽  
Saroj Neupane ◽  
Mir Basir ◽  
Khaldoon Alaswad

Abstract Background Gadolinium-based contrast agents have been used as an alternative to iodinated contrast agents for simple percutaneous coronary interventions (PCIs) in patients with obstructive coronary artery disease. Their use has been limited in complex PCI due to poor image quality with gadolinium contrast. Significant dilution of gadolinium is required in an effort to avoid malignant ventricular arrhythmias. Further, the recommended amount of gadolinium contrast that can be used is very limited. Case summary We describe a case of patient with severe anaphylaxis to iodinated contrast agents despite pre-exposure prophylaxis with steroids and histamine blockers who underwent intravascular imaging-guided PCI of chronic total occlusions (CTOs) of left anterior descending and dominant left circumflex arteries using gadolinium contrast. Discussion In patients with anaphylaxis to iodinated contrast agents (i) complex coronary interventions including CTO PCI can be successfully performed without use of iodinated contrast, and (ii) combination of intravascular ultrasound guidance and gadolinium-based contrast agents can be safely and effectively used to perform complex PCI.

2015 ◽  
Vol 12 (C) ◽  
pp. 24
Author(s):  
Leszek Bryniarski* ◽  
Slawomir Surowiec ◽  
Lukasz Klima ◽  
Michal Terlecki ◽  
Piotr Jankowski ◽  
...  

2009 ◽  
Vol 62 (7-8) ◽  
pp. 331-336 ◽  
Author(s):  
Zdravko Mijailovic ◽  
Zoran Stajic ◽  
Miodrag Jevtic ◽  
Srdjan Aleksandric ◽  
Radomir Matunovic ◽  
...  

While the performance of percutaneous coronary interventions remains the domain of interventional cardiologists, the management of these patients before, during, and after the procedure is in the domain of general cardiologists, internists and primary care physicians. Therefore, for optimal patient care it is crucial that all engaged physicians should understand the procedural risks, complications and optimal treatment strategy before, during and after the procedure. Before a percutaenous coronary intervention, patients with known allergies to iodinated contrast dye should be pretreated with oral corticosteroids and H1-receptor blockers. Diabetic patients as well as patients with renal failure need special care. Hydration is crucial for patients with renal insufficiency in order to minimise the risk of contrast nephropathy. Metformin therapy should be discontinued before the procedure in patients with renal failure in order to avoid lactic acidosis, and it should be reinstituted after the procedure only when normal serum creatine level is confirmed. Double antiplatelet therapy (aspirin plus clopidogrel) should be initiated at least six hours before the procedure. While aspirin therapy after the procedure is life long, the duration of clopidogrel therapy depends on the type of implanted stent (in patients with bare stents implanted clopidogrel should be taken at least 3 - 4 weeks post procedural, and in patients with drug-eluting stents implanted clopidogrel should be taken at least 6 - 12 months after the procedure due to in-stent restenosis prevention). Patients who experience typical anginal pain in a period of one to eight month after percutaneous coronary revascularization are likely to have restenosis, and they should be reevaluated with stress echocardiography and/or repeated coronary angiography.


2017 ◽  
Vol 13 (12) ◽  
pp. e1489-e1490 ◽  
Author(s):  
Kambis Mashayekhi ◽  
Zivile Valuckiene ◽  
Hans Neuser ◽  
Ibrahim Akin ◽  
Nicolaus Reifart ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document